Lawrence P. Guiheen - 13 Mar 2026 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Lawrence P. Guiheen, by Michael A. Goldstein as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
13 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 21:00:33 UTC
Previous filing
11 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Guiheen Lawrence P. Director C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY /s/ Lawrence P. Guiheen, by Michael A. Goldstein as Attorney-in-fact 17 Mar 2026 0001554353

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Options Exercise +30,000 +28% $3.66* 135,520 13 Mar 2026 Direct F1
transaction ADMA Common Stock Gift -30,000 -22% $0.000000* 105,520 17 Mar 2026 Direct F1, F2
transaction ADMA Common Stock Gift +30,000 $0.000000* 30,000 17 Mar 2026 See footnote F2, F3
holding ADMA Common Stock 50,990 13 Mar 2026 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Stock Option (Right to Buy) Options Exercise -30,000 -56% $0.000000* 23,837 13 Mar 2026 Common Stock 30,000 $3.66 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 94,830 shares of common stock owned by the Reporting Person.
F2 This transaction involved the Reporting Person's gift of 30,000 shares of Issuer common stock to the Lawrence P Guiheen Irrevocable Trust DTD 9/20/19, Arlene Guiheen TTEE, Katherine M Guiheen TTEE (the "2019 Guiheen Irrevocable Trust"), over which Mr. Guiheen retains control. The Reporting Person disclaims beneficial ownership of the securities held by the 2019 Guiheen Irrevocable Trust, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F3 Includes 30,000 shares of common stock held in the 2019 Guiheen Irrevocable Trust.
F4 Includes 50,990 shares of common stock held in the Lawrence P Guiheen Irrevocable Trust 1.
F5 The Reporting Person is exercising this option due, in part, to its near-term expiration date.
F6 These options vested in twenty-four equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.